论文信息 - Mutation in the ITPA Gene Predicts Intolerance to Azathioprine

Mutation in the ITPA Gene Predicts Intolerance to Azathioprine

Inosine triphosphate pyrophosphatase (ITPase) deficiency occurs with polymorphic frequencies in Caucasians and results in the benign accumulation of the inosine nucleotide ITP. In 62 patients treated with azathioprine for inflammatory bowel disease, the ITPA 94C > A deficiency‐associated allele was significantly associated with adverse drug reactions (OR 4.2, 95% CI 1.6–11.5, p = 0.0034). Significant associations were found for flu‐like symptoms (OR 4.7, 95% CI 1.2–18.1, p = 0.0308), rash (OR 10.3, 95% CI 4.7–62.9, p = 0.0213) and pancreatitis (OR 6.2,CI 1.1–32.6, p = 0.0485). Polymorphism in the ITPA gene thus predicts AZA intolerance. Alternative immunosuppressive drugs, particularly 6‐thioguanine, should be considered for AZA‐intolerant patients with ITPase deficiency.

[1] C Hassan,et al. Thiopurine methyltransferase activity and the use of azathioprine in inflammatory bowel disease , 2002, Alimentary pharmacology & therapeutics.

[2] J. Sanderson,et al. Genetic basis of inosine triphosphate pyrophosphohydrolase deficiency , 2002, Human Genetics.

[3] L. Lennard,et al. TPMT in the treatment of Crohn's disease with azathioprine , 2002, Gut.

[4] S. Targan,et al. An Open-Label Pilot Study Using Thioguanine as a Therapeutic Alternative in Crohn's Disease Patients Resistant to 6-Mercaptopurine Therapy , 2001, Inflammatory bowel diseases.